UnitedHealth Group (NYSE: UNH) has seen its shares plummet over 40% this year, making it the worst-performing stock in the Dow Jones Industrial Average.
Key issues contributing to this decline include a downward revision in earnings guidance—from $28.15 to $28.65 per share to $24.65 to $25.15—due to higher-than-expected costs from Medicare Advantage and challenges in its Optum Health division. Additionally, CEO Andrew Witty’s recent resignation and an investigation by the Department of Justice regarding Medicare billing fraud have added to investor concerns.
As of June 3, shares are trading around $300, nearing a five-year low, and the company faces increased scrutiny surrounding its leadership and operational issues.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
